Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PDSG (This is completely unacceptable (Revenue 47,587)
Consolidated:
Three months ended
November 3 0 , 2011
November 30, 2010
Dollars
% of Revenue
Dollars
% of Revenue
Revenue:
License and service revenue
$ 47,587 100.0% $ 72,775 100.0%
Cost of sales:
License and service revenue
12,313 25.9% 5,000 6.9%
Amortization of purchased intangibles
- - 68,889 94.7%
Total cost of sales
12,313 25.9% 73,889 -
Gross profit (loss)
$ 35,274 74.1% $ (1,114 ) -
PDSG

Revenue consisting of software licenses and associated services relating to PDSG’s CDX product decreased from approximately $73,000 for the three months ended November 30, 2010 to approximately $48,000 for the three months ended November 30, 2011. The decrease was primarily due to the level of activity and progress towards completion rendered on one time contracts that vary in size and scope depending upon the requirements of the customer. Cost of sales includes the direct time of PDSG employees on each project. Included in cost of sales is approximately $68,900 of amortization expense on purchased intangible assets for the three months ended November 30, 2010. Profit margin excluding amortization decreased for the three months ended November 30, 2011 as compared to the three months ended November 30, 2010 due to a greater portion of service revenue generated in the current period as compared to the prior period. During fiscal 2011, we wrote off PDSG’s remaining balance of purchased intangible assets.
Share
New Message
Please login to post a reply